Holdings of BIOTECHNOLOGY ULTRASECTOR PROFUND
ProFunds · Original filing · Compare with another fund · Report an error
- Net assets
- 182.6M $ including 132M $ in equities, 72.3 %
- Positions
- 145 in 6 countries
- Top ten
- 10.7 % of net assets
- Filed on
- Apr 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Apellis Pharmaceuticals Inc | 60,117 | 2.5M $ | 1.35 % |
| 2 | Revolution Medicines Inc | 15,087 | 2.2M $ | 1.19 % |
| 3 | Travere Therapeutics Inc | 50,777 | 2.1M $ | 1.17 % |
| 4 | Arrowhead Pharmaceuticals Inc | 25,860 | 1.9M $ | 1.04 % |
| 5 | Twist Bioscience Corp | 32,063 | 1.9M $ | 1.03 % |
| 6 | Summit Therapeutics Inc | 86,301 | 1.9M $ | 1.01 % |
| 7 | Alkermes PLC | 54,105 | 1.8M $ | 1.00 % |
| 8 | TG Therapeutics Inc | 53,565 | 1.8M $ | 0.99 % |
| 9 | Madrigal Pharmaceuticals Inc | 3,482 | 1.8M $ | 0.99 % |
| 10 | Beam Therapeutics Inc | 57,611 | 1.7M $ | 0.96 % |
| 11 | Apogee Therapeutics Inc | 20,119 | 1.7M $ | 0.91 % |
| 12 | Scholar Rock Holding Corp | 34,796 | 1.6M $ | 0.89 % |
| 13 | Praxis Precision Medicines Inc | 5,059 | 1.6M $ | 0.88 % |
| 14 | Exelixis Inc | 35,988 | 1.6M $ | 0.88 % |
| 15 | Mirum Pharmaceuticals Inc | 16,376 | 1.6M $ | 0.87 % |
| 16 | United Therapeutics Corp | 2,758 | 1.6M $ | 0.86 % |
| 17 | Natera Inc | 7,642 | 1.6M $ | 0.86 % |
| 18 | CRISPR Therapeutics AG | 30,092 | 1.6M $ | 0.86 % |
| 19 | Celcuity Inc | 12,979 | 1.6M $ | 0.86 % |
| 20 | Krystal Biotech Inc | 5,892 | 1.5M $ | 0.85 % |
| 21 | Protagonist Therapeutics Inc | 15,573 | 1.5M $ | 0.84 % |
| 22 | Neurocrine Biosciences Inc | 11,599 | 1.5M $ | 0.84 % |
| 23 | Incyte Corp | 15,873 | 1.5M $ | 0.83 % |
| 24 | CG oncology Inc | 22,645 | 1.5M $ | 0.83 % |
| 25 | Cytokinetics Inc | 23,613 | 1.5M $ | 0.83 % |
| 26 | Nuvalent Inc | 15,017 | 1.5M $ | 0.82 % |
| 27 | Ionis Pharmaceuticals Inc | 20,089 | 1.5M $ | 0.82 % |
| 28 | Bridgebio Pharma Inc | 21,046 | 1.5M $ | 0.82 % |
| 29 | Vaxcyte Inc | 26,117 | 1.5M $ | 0.82 % |
| 30 | Kymera Therapeutics Inc | 18,431 | 1.5M $ | 0.82 % |
| 31 | Biogen Inc | 7,888 | 1.5M $ | 0.82 % |
| 32 | Cogent Biosciences Inc | 41,643 | 1.5M $ | 0.82 % |
| 33 | PTC Therapeutics Inc | 22,879 | 1.5M $ | 0.82 % |
| 34 | Insmed Inc | 10,778 | 1.5M $ | 0.80 % |
| 35 | Alnylam Pharmaceuticals Inc | 4,689 | 1.5M $ | 0.79 % |
| 36 | Roivant Sciences Ltd | 50,794 | 1.4M $ | 0.79 % |
| 37 | Halozyme Therapeutics Inc | 22,601 | 1.4M $ | 0.79 % |
| 38 | Arcutis Biotherapeutics Inc | 60,967 | 1.4M $ | 0.78 % |
| 39 | Spyre Therapeutics Inc | 18,961 | 1.4M $ | 0.77 % |
| 40 | Soleno Therapeutics Inc | 26,523 | 1.4M $ | 0.77 % |
| 41 | AbbVie Inc | 6,599 | 1.4M $ | 0.76 % |
| 42 | Amgen Inc | 3,979 | 1.4M $ | 0.75 % |
| 43 | Regeneron Pharmaceuticals, Inc. | 1,940 | 1.4M $ | 0.75 % |
| 44 | Ultragenyx Pharmaceutical Inc | 55,107 | 1.4M $ | 0.75 % |
| 45 | ACADIA Pharmaceuticals Inc | 60,518 | 1.4M $ | 0.74 % |
| 46 | Rhythm Pharmaceuticals Inc | 16,691 | 1.4M $ | 0.74 % |
| 47 | Gilead Sciences Inc | 10,291 | 1.3M $ | 0.74 % |
| 48 | BioMarin Pharmaceutical Inc | 24,909 | 1.3M $ | 0.74 % |
| 49 | Viking Therapeutics Inc | 42,016 | 1.3M $ | 0.72 % |
| 50 | Vertex Pharmaceuticals Inc | 3,051 | 1.3M $ | 0.71 % |
| 51 | ImmunityBio Inc | 181,680 | 1.3M $ | 0.71 % |
| 52 | Immunovant Inc | 45,510 | 1.2M $ | 0.68 % |
| 53 | Moderna Inc | 26,845 | 1.2M $ | 0.68 % |
| 54 | Vera Therapeutics Inc | 33,906 | 1.2M $ | 0.66 % |
| 55 | Immunome Inc | 52,038 | 1.2M $ | 0.65 % |
| 56 | Disc Medicine Inc | 17,945 | 1.2M $ | 0.65 % |
| 57 | Veracyte Inc | 34,714 | 1.1M $ | 0.63 % |
| 58 | Sarepta Therapeutics Inc | 54,198 | 1.1M $ | 0.62 % |
| 59 | Catalyst Pharmaceuticals Inc | 40,217 | 1.1M $ | 0.62 % |
| 60 | BioCryst Pharmaceuticals Inc | 118,008 | 1.1M $ | 0.59 % |
| 61 | Dyne Therapeutics Inc | 60,951 | 1.1M $ | 0.59 % |
| 62 | Kodiak Sciences Inc | 23,819 | 1M $ | 0.57 % |
| 63 | Recursion Pharmaceuticals Inc | 296,667 | 1M $ | 0.56 % |
| 64 | GRAIL Inc | 18,462 | 1M $ | 0.55 % |
| 65 | Arcus Biosciences Inc | 38,352 | 978K $ | 0.54 % |
| 66 | Agios Pharmaceuticals Inc | 34,224 | 958.3K $ | 0.52 % |
| 67 | Denali Therapeutics Inc | 50,195 | 939.7K $ | 0.51 % |
| 68 | Oruka Therapeutics Inc | 13,486 | 922.6K $ | 0.51 % |
| 69 | Dianthus Therapeutics Inc | 10,400 | 913.1K $ | 0.50 % |
| 70 | Intellia Therapeutics Inc | 66,541 | 897K $ | 0.49 % |
| 71 | Erasca Inc | 83,931 | 893.9K $ | 0.49 % |
| 72 | ADMA Biologics Inc | 87,175 | 893.5K $ | 0.49 % |
| 73 | Syndax Pharmaceuticals Inc | 41,547 | 890.4K $ | 0.49 % |
| 74 | Ardelyx Inc | 135,861 | 860K $ | 0.47 % |
| 75 | Ideaya Biosciences Inc | 28,876 | 840.3K $ | 0.46 % |
| 76 | Mineralys Therapeutics Inc | 31,432 | 837.7K $ | 0.46 % |
| 77 | Nurix Therapeutics Inc | 49,808 | 831.8K $ | 0.46 % |
| 78 | Tango Therapeutics Inc | 34,963 | 755.9K $ | 0.41 % |
| 79 | Celldex Therapeutics Inc | 21,669 | 712.5K $ | 0.39 % |
| 80 | Capricor Therapeutics Inc | 20,771 | 697.5K $ | 0.38 % |
| 81 | Vericel Corp | 19,785 | 687.1K $ | 0.38 % |
| 82 | Inhibrx Biosciences Inc | 5,251 | 678.5K $ | 0.37 % |
| 83 | Monte Rosa Therapeutics Inc | 34,850 | 667.4K $ | 0.37 % |
| 84 | Novavax Inc | 82,749 | 655.8K $ | 0.36 % |
| 85 | Biohaven Ltd | 68,137 | 653.4K $ | 0.36 % |
| 86 | Stoke Therapeutics Inc | 19,953 | 652.9K $ | 0.36 % |
| 87 | Relay Therapeutics Inc | 50,173 | 650.2K $ | 0.36 % |
| 88 | Taysha Gene Therapies Inc | 99,901 | 638.4K $ | 0.35 % |
| 89 | Viridian Therapeutics Inc | 47,295 | 637.5K $ | 0.35 % |
| 90 | Olema Pharmaceuticals Inc | 43,811 | 631.3K $ | 0.35 % |
| 91 | Palvella Therapeutics Inc | 4,860 | 623.6K $ | 0.34 % |
| 92 | uniQure NV | 30,072 | 599.9K $ | 0.33 % |
| 93 | AnaptysBio Inc | 9,076 | 596.6K $ | 0.33 % |
| 94 | Corvus Pharmaceuticals Inc | 37,511 | 569.8K $ | 0.31 % |
| 95 | MannKind Corp | 193,714 | 548.2K $ | 0.30 % |
| 96 | CareDx Inc | 26,227 | 545.8K $ | 0.30 % |
| 97 | KalVista Pharmaceuticals Inc | 19,086 | 508.8K $ | 0.28 % |
| 98 | Iovance Biotherapeutics Inc | 144,237 | 484.6K $ | 0.27 % |
| 99 | Vir Biotechnology Inc | 44,774 | 457.4K $ | 0.25 % |
| 100 | Geron Corp | 294,335 | 453.3K $ | 0.25 % |
Sector breakdown
- Health care 14.1 %
- Unattributed 85.9 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 95.2 %
- Ireland 1.5 %
- Switzerland 1.2 %
- Bermuda 1.1 %
- British Virgin Islands 0.5 %
- Netherlands 0.5 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 139 | 125.7M $ | 95.23 % |
| 2 | Ireland | 2 | 2M $ | 1.53 % |
| 3 | Switzerland | 1 | 1.6M $ | 1.19 % |
| 4 | Bermuda | 1 | 1.4M $ | 1.10 % |
| 5 | British Virgin Islands | 1 | 653.4K $ | 0.50 % |
| 6 | Netherlands | 1 | 599.9K $ | 0.45 % |
Cite this page
Titelia. "Holdings of BIOTECHNOLOGY ULTRASECTOR PROFUND". https://titelia.com/en/funds/S000003107